The test measures the expression levels of three exosomal RNA biomarkers—ERG (ETS-related gene), PCA3 (prostate cancer antigen 3), and SPDEF (SAM pointed domain-containing ETS transcription factor)—which are associated with prostate tumor formation [57]. Here, PCA3 is linked to prostate neoplasm.